Skip to content

Clinical trials

Phase 2 Basal Cell Carcinoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Basal Cell Carcinoma Phase: Phase 2 Country / region: Germany Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20113
20131
20172
20201
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Philogen S.p.A.3
Hoffmann-La Roche2
Novartis Pharmaceuticals2
Genentech, Inc.1
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1
Regeneron Pharmaceuticals1
SRH Wald-Klinikum Gera GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Basal Cell Carcinoma11
Skin Neoplasms2
Basal Cell Nevus Syndrome1
Carcinoma1
Neoplasms, Basal Cell1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.